Alterations in endogenous brain β-endorphin release by adrenal medullary transplants in the spinal cord

Gal Yadid, Abraham Zangen, Uri Herzberg, R. Nakash, Jacqueline Sagen

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

While transplants of adrenal medullary cells into the spinal subarachnoid space may produce antinociception via inhibition of spinal pain transmission pathways, alterations at higher central nervous system (CNS) centers have not been addressed. Recent findings suggest that prolonged noxious stimulation results in release of endogenous β-endorphin in the brain, possibly as a compensatory mechanism to reduce nociception. The goal of this study was to determine whether adrenal medullary transplants in the spinal subarachnoid space alter endogenous β-endorphin secretion in the hypothalamic arcuate nucleus, its principal CNS source. Pain behaviors and arcuate β-endorphin secretion by microdialysis were monitored during the formalin pain test in animals with spinal adrenal medullary or control transplants. Basal levels of extracellular β-endorphin were 3-fold higher in adrenal medullary-implanted than in controls. In control animals, formalin induced robust pain behaviors and a marked transient increase in β-endorphin release 30-60 min following injection. In contrast, pain behaviors were attenuated and the formalin-induced increase in β-endorphin was completely blocked in adrenal medullary implanted animals. Findings from these studies indicate that adrenal medullary transplants in the spinal subarachnoid space can alter β-endorphin release in the arcuate nucleus both basally and in response to noxious stimuli. Thus, spinally placed adrenal medullary transplants not only alter local spinal cord pharmacology, but can alter endogenous neurochemistry at higher pain processing centers as well. Copyright (C) 2000 American College of Neuropsychopharmacology.

Original languageEnglish
Pages (from-to)709-716
Number of pages8
JournalNeuropsychopharmacology
Volume23
Issue number6
DOIs
StatePublished - Nov 1 2000

Fingerprint

Endorphins
Spinal Cord
Transplants
Brain
Subarachnoid Space
Pain
Arcuate Nucleus of Hypothalamus
Formaldehyde
Central Nervous System
Neurochemistry
Pain Clinics
Nociception
Microdialysis
Pain Measurement
Pharmacology
Injections

Keywords

  • Analgesia
  • Chromaffin cells
  • Intrathecal
  • Neural transplants
  • Nociception
  • Opioid peptides

ASJC Scopus subject areas

  • Pharmacology

Cite this

Alterations in endogenous brain β-endorphin release by adrenal medullary transplants in the spinal cord. / Yadid, Gal; Zangen, Abraham; Herzberg, Uri; Nakash, R.; Sagen, Jacqueline.

In: Neuropsychopharmacology, Vol. 23, No. 6, 01.11.2000, p. 709-716.

Research output: Contribution to journalArticle

Yadid, Gal ; Zangen, Abraham ; Herzberg, Uri ; Nakash, R. ; Sagen, Jacqueline. / Alterations in endogenous brain β-endorphin release by adrenal medullary transplants in the spinal cord. In: Neuropsychopharmacology. 2000 ; Vol. 23, No. 6. pp. 709-716.
@article{4b6e52c7b79847eaadf8dcae27ff8c64,
title = "Alterations in endogenous brain β-endorphin release by adrenal medullary transplants in the spinal cord",
abstract = "While transplants of adrenal medullary cells into the spinal subarachnoid space may produce antinociception via inhibition of spinal pain transmission pathways, alterations at higher central nervous system (CNS) centers have not been addressed. Recent findings suggest that prolonged noxious stimulation results in release of endogenous β-endorphin in the brain, possibly as a compensatory mechanism to reduce nociception. The goal of this study was to determine whether adrenal medullary transplants in the spinal subarachnoid space alter endogenous β-endorphin secretion in the hypothalamic arcuate nucleus, its principal CNS source. Pain behaviors and arcuate β-endorphin secretion by microdialysis were monitored during the formalin pain test in animals with spinal adrenal medullary or control transplants. Basal levels of extracellular β-endorphin were 3-fold higher in adrenal medullary-implanted than in controls. In control animals, formalin induced robust pain behaviors and a marked transient increase in β-endorphin release 30-60 min following injection. In contrast, pain behaviors were attenuated and the formalin-induced increase in β-endorphin was completely blocked in adrenal medullary implanted animals. Findings from these studies indicate that adrenal medullary transplants in the spinal subarachnoid space can alter β-endorphin release in the arcuate nucleus both basally and in response to noxious stimuli. Thus, spinally placed adrenal medullary transplants not only alter local spinal cord pharmacology, but can alter endogenous neurochemistry at higher pain processing centers as well. Copyright (C) 2000 American College of Neuropsychopharmacology.",
keywords = "Analgesia, Chromaffin cells, Intrathecal, Neural transplants, Nociception, Opioid peptides",
author = "Gal Yadid and Abraham Zangen and Uri Herzberg and R. Nakash and Jacqueline Sagen",
year = "2000",
month = "11",
day = "1",
doi = "10.1016/S0893-133X(00)00152-4",
language = "English",
volume = "23",
pages = "709--716",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Alterations in endogenous brain β-endorphin release by adrenal medullary transplants in the spinal cord

AU - Yadid, Gal

AU - Zangen, Abraham

AU - Herzberg, Uri

AU - Nakash, R.

AU - Sagen, Jacqueline

PY - 2000/11/1

Y1 - 2000/11/1

N2 - While transplants of adrenal medullary cells into the spinal subarachnoid space may produce antinociception via inhibition of spinal pain transmission pathways, alterations at higher central nervous system (CNS) centers have not been addressed. Recent findings suggest that prolonged noxious stimulation results in release of endogenous β-endorphin in the brain, possibly as a compensatory mechanism to reduce nociception. The goal of this study was to determine whether adrenal medullary transplants in the spinal subarachnoid space alter endogenous β-endorphin secretion in the hypothalamic arcuate nucleus, its principal CNS source. Pain behaviors and arcuate β-endorphin secretion by microdialysis were monitored during the formalin pain test in animals with spinal adrenal medullary or control transplants. Basal levels of extracellular β-endorphin were 3-fold higher in adrenal medullary-implanted than in controls. In control animals, formalin induced robust pain behaviors and a marked transient increase in β-endorphin release 30-60 min following injection. In contrast, pain behaviors were attenuated and the formalin-induced increase in β-endorphin was completely blocked in adrenal medullary implanted animals. Findings from these studies indicate that adrenal medullary transplants in the spinal subarachnoid space can alter β-endorphin release in the arcuate nucleus both basally and in response to noxious stimuli. Thus, spinally placed adrenal medullary transplants not only alter local spinal cord pharmacology, but can alter endogenous neurochemistry at higher pain processing centers as well. Copyright (C) 2000 American College of Neuropsychopharmacology.

AB - While transplants of adrenal medullary cells into the spinal subarachnoid space may produce antinociception via inhibition of spinal pain transmission pathways, alterations at higher central nervous system (CNS) centers have not been addressed. Recent findings suggest that prolonged noxious stimulation results in release of endogenous β-endorphin in the brain, possibly as a compensatory mechanism to reduce nociception. The goal of this study was to determine whether adrenal medullary transplants in the spinal subarachnoid space alter endogenous β-endorphin secretion in the hypothalamic arcuate nucleus, its principal CNS source. Pain behaviors and arcuate β-endorphin secretion by microdialysis were monitored during the formalin pain test in animals with spinal adrenal medullary or control transplants. Basal levels of extracellular β-endorphin were 3-fold higher in adrenal medullary-implanted than in controls. In control animals, formalin induced robust pain behaviors and a marked transient increase in β-endorphin release 30-60 min following injection. In contrast, pain behaviors were attenuated and the formalin-induced increase in β-endorphin was completely blocked in adrenal medullary implanted animals. Findings from these studies indicate that adrenal medullary transplants in the spinal subarachnoid space can alter β-endorphin release in the arcuate nucleus both basally and in response to noxious stimuli. Thus, spinally placed adrenal medullary transplants not only alter local spinal cord pharmacology, but can alter endogenous neurochemistry at higher pain processing centers as well. Copyright (C) 2000 American College of Neuropsychopharmacology.

KW - Analgesia

KW - Chromaffin cells

KW - Intrathecal

KW - Neural transplants

KW - Nociception

KW - Opioid peptides

UR - http://www.scopus.com/inward/record.url?scp=0033788016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033788016&partnerID=8YFLogxK

U2 - 10.1016/S0893-133X(00)00152-4

DO - 10.1016/S0893-133X(00)00152-4

M3 - Article

VL - 23

SP - 709

EP - 716

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 6

ER -